The science could lead to cures for cancer and many inherited diseases. But monopoly patents hinder that promise. Myriad Genetics, for example, found a gene that causes inherited breast cancer and licensed the therapeutic development rights to Eli Lilly. Activists worry that exclusive patent rights over the gene could lead to more expensive gene screening tests and treatments.
Patents give companies the right to determine who gets access to genes and at what price.
All letters to the editor are for publication and may be edited for length and clarity.